رد مشاركة : مشروع ترجمة موسوعة التكنولوجيا الصيدلية الجماعي...
السلام عليكم
هذه مجموعة من الأقسام المحجوزة حديثاً
الدكتور محمد أمين لطلاب حلقات البحث
Bioabsorbable Polymers = Shalaby W. Shalaby . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
Biodegradable Polymers as Drug Carriers = Peter Markland and Victor C. Yang . . . . . . . . . . . 176
Biotechnology-Derived Drug Products: Formulation Development =
Mary E.M. Cromwell . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 281
Calorimetry in Pharmaceutical Research and Development = Sophie-Dorothe´e Clas,
Chad R. Dalton, and Bruno C. Hancock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 393
Coacervation and Phase Separation = Bruno Gander, Maria Jose Blanco-Prı´eto,
C. Thomasin, Ch. Wandrey, and D. Hunkeler . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 600
Cocrystals: Design, Properties and Formation Mechanisms = Naı´r Rodrı´guez-Hornedo,
Sarah J. Nehm, and Adivaraha Jayasankar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 615
Complexation: Cyclodextrins = Gerold Mosher and Diane O. Thompson . . . . . . . . . . . . . . . . 671
Complexation: Non-Cyclodextrins = Galina N. Kalinkova . . . . . . . . . . . . . . . . . . . . . . . . . . 697
Computer Systems Validation = Orlando Lopez . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 707
Computer-Assisted Drug Design = J. Phillip Bowen and Michael Cory . . . . . . . . . . . . . . . . . . 714
Computers in Pharmaceutical Technology = Onkaram Basavapathruni . . . . . . . . . . . . . . . . . . 732
Cooling Processes and Congealing = Richard Turton and Xiu Xiu Cheng . . . . . . . . . . . . . . . . 761
Coprecipitates and Melts = Madhu K. Vadnere . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 774
Corrosion of Pharmaceutical Equipment = Paul K. Whitcraft . . . . . . . . . . . . . . . . . . . . . . . . 782
Cosolvents and Cosolvency = Joseph T. Rubino . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 806
Crystal Habit Changes and Dosage Form Performance = A. K. Tiwary . . . . . . . . . . . . . . . . . . 820
Crystallization: General Principles and Significance on Product Development =
Naı´r Rodrı´guez-Hornedo, Ron C. Kelly, Brent D. Sinclair, and Jonathan M. Miller . . . . . . . 834
Drug Delivery: Liquid Crystals in = Christel C. Mueller-Goymann . . . . . . . . . . . . . . . . . . . . 1115
Electrostatic Charge in Pharmaceutical Systems = Philip Chi Lip Kwok and
Hak-Kim Chan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1535
Freeze Drying, Scale-Up Considerations = Edward H. Trappler . . . . . . . . . . . . . . . . . . . . . . 1834
Homogenization and Homogenizers = Shailesh K. Singh and Venkatesh Naini . . . . . . . . . . . . . 1996
Hot-Melt Extrusion Technology = Jim W. McGinity, Michael A. Repka,
John J. Koleng, Jr., and Feng Zhang . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2004
_______________________________________________________________
م م
Clinical Pharmacokinetics and Pharmacodynamics = Leslie Z. Benet and
Laviero Mancinelli . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 572
كريم
Drug Delivery: Nanoparticles = Elias Fattal and Christine Vauthier . . . . . . . . . . . . . . . . . . . 1183
ف غ
Drug Delivery: Pulsatile Systems = Till Bussemer and Roland A. Bodmeier . . . . . . . . . . . . . . . 1287
الهدهد
Drug Design: Basic Principles and Applications = Jacques H. Poupaert . . . . . . . . . . . . . . . . . . 1362
ه ع
Drug Safety Evaluation = Farrel L. Fort . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1406
سارية
Dry Powder Aerosols: Emerging Technologies = Hak-Kim Chan and Nora Y.K. Chew . . . . . . . . 1428
علاء محمد
Electrochemical Detection for Pharmaceutical Analysis = Craig E. Lunte and
Damon Osbourn . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1516
ب ج
Excipients for Pharmaceutical Dosage Forms = Patrick J. Crowley and Luigi G. Martini . . . . . . 1609
ما من
Expiration Dating = Leslie C. Hawley and Mark D. VanArendonk . . . . . . . . . . . . . . . . . . . . 1685
RN
Good Clinical Practices (GCPs): An Overview = Richard A. Guarino . . . . . . . . . . . . . . . . . . . 1925
ا ط
Health Care Systems: Outside the United States = Albert I. Wertheimer and
Sheldon X. Kong . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1977
لا حد
Health Care Systems: Within the United States = Henri R. Manasse, Jr. . . . . . . . . . . . . . . . . . 1985
أبو عمر
Medication Errors = Diane D. Cousins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2243
Peptides and Proteins: Non-Invasive Delivery = Michael R. DeFelippis,
Muppalla Sukumar, and Natarajan Rajagopalan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2692
smile
Partition Coefficients = Eric J. Lien and Steven Shijun Ren . . . . . . . . . . . . . . . . . . . . . . . . 2595
خ ط
Peptides and Proteins: Oral Absorption = Eugene J. McNally and Jung Y. Park . . . . . . . . . . . . 2713
عبد الرحمن
Pharmacopeial Standards: European Pharmacopeia = Agne`s Artiges . . . . . . . . . . . . . . . . . . . . 2829
رامز
Powders as Dosage Forms = Jean-Marc Aiache and Erick Beyssac . . . . . . . . . . . . . . . . . . . . 2971
م ج
Pyrogens and Endotoxin Detection = James F. Cooper . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3052
م س
Surfactants in Pharmaceutical Products and Systems = Owen I. Corrigan and
Anne Marie Healy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3583